beta-catenin is a target for the ubiquitin-proteasome pathway - PubMed (original) (raw)
beta-catenin is a target for the ubiquitin-proteasome pathway
H Aberle et al. EMBO J. 1997.
Abstract
beta-catenin is a central component of the cadherin cell adhesion complex and plays an essential role in the Wingless/Wnt signaling pathway. In the current model of this pathway, the amount of beta-catenin (or its invertebrate homolog Armadillo) is tightly regulated and its steady-state level outside the cadherin-catenin complex is low in the absence of Wingless/Wnt signal. Here we show that the ubiquitin-dependent proteolysis system is involved in the regulation of beta-catenin turnover. beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin. Mutagenesis experiments demonstrate that substitution of the serine residues in the glycogen synthase kinase 3beta (GSK3beta) phosphorylation consensus motif of beta-catenin inhibits ubiquitination and results in stabilization of the protein. This motif in beta-catenin resembles a motif in IkappaB (inhibitor of NFkappaB) which is required for the phosphorylation-dependent degradation of IkappaB via the ubiquitin-proteasome pathway. We show that ubiquitination of beta-catenin is greatly reduced in Wnt-expressing cells, providing the first evidence that the ubiquitin-proteasome degradation pathway may act downstream of GSK3beta in the regulation of beta-catenin.
Similar articles
- Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45.
Hagen T, Vidal-Puig A. Hagen T, et al. Biochem Biophys Res Commun. 2002 Jun 7;294(2):324-8. doi: 10.1016/S0006-291X(02)00485-0. Biochem Biophys Res Commun. 2002. PMID: 12051714 - Differential interaction of plakoglobin and beta-catenin with the ubiquitin-proteasome system.
Sadot E, Simcha I, Iwai K, Ciechanover A, Geiger B, Ben-Ze'ev A. Sadot E, et al. Oncogene. 2000 Apr 13;19(16):1992-2001. doi: 10.1038/sj.onc.1203519. Oncogene. 2000. PMID: 10803460 - Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription.
Bonvini P, An WG, Rosolen A, Nguyen P, Trepel J, Garcia de Herreros A, Dunach M, Neckers LM. Bonvini P, et al. Cancer Res. 2001 Feb 15;61(4):1671-7. Cancer Res. 2001. PMID: 11245482 - The role of the proteasome in cellular protein degradation.
Driscoll J. Driscoll J. Histol Histopathol. 1994 Jan;9(1):197-202. Histol Histopathol. 1994. PMID: 8003815 Review. - [Ubiquitin-dependent proteolysis by SCF complex].
Nakayama K, Nakayama K. Nakayama K, et al. Seikagaku. 2000 Feb;72(2):113-7. Seikagaku. 2000. PMID: 10737103 Review. Japanese. No abstract available.
Cited by
- Development of novel osteoarthritis therapy by targeting AMPK-β-catenin-Runx2 signaling.
Zeng D, Umar M, Zhu Z, Pan H, Lu WW, Xiao G, Chen Y, Tong L, Chen D. Zeng D, et al. Genes Dis. 2024 Feb 24;12(1):101247. doi: 10.1016/j.gendis.2024.101247. eCollection 2025 Jan. Genes Dis. 2024. PMID: 39552787 Free PMC article. Review. - Mechano-gradients drive morphogen-noise correction to ensure robust patterning.
Aoki K, Higuchi T, Akieda Y, Matsubara K, Ohkawa Y, Ishitani T. Aoki K, et al. Sci Adv. 2024 Nov 15;10(46):eadp2357. doi: 10.1126/sciadv.adp2357. Epub 2024 Nov 15. Sci Adv. 2024. PMID: 39546611 Free PMC article. - The E3 Ubiquitin Ligase Trip12 attenuates Wnt9a/Fzd9b signaling during hematopoietic stem cell development.
Ensing J, Ide AD, Gilliland C, Tsurho V, Caza I, Stratman AN, Lanning NJ, Grainger S. Ensing J, et al. bioRxiv [Preprint]. 2024 Oct 25:2024.10.25.620301. doi: 10.1101/2024.10.25.620301. bioRxiv. 2024. PMID: 39484584 Free PMC article. Preprint. - Combinatorial Effects of 5-Fluorouracil and Menadione on Wnt/β-Catenin Pathway in Human Colorectal Cancer Cells.
Warrier VP, Venkatachalam S, Sakthivel R, Gromiha MM, Karunagaran D. Warrier VP, et al. Appl Biochem Biotechnol. 2024 Oct 15. doi: 10.1007/s12010-024-05072-5. Online ahead of print. Appl Biochem Biotechnol. 2024. PMID: 39404999 - Targeting CircAURKA prevents colorectal cancer progression via enhancing CTNNB1 protein degradation.
Sun Z, Dang P, Guo Y, Liu S, Hu S, Sun H, Xu Y, Wang W, Chen C, Liu J, Ji Z, Liu Y, Hu J. Sun Z, et al. Oncogene. 2024 Nov;43(46):3388-3401. doi: 10.1038/s41388-024-03155-5. Epub 2024 Sep 28. Oncogene. 2024. PMID: 39341990
References
- Mol Cell Biol. 1985 Dec;5(12):3610-6 - PubMed
- Curr Opin Cell Biol. 1996 Oct;8(5):685-91 - PubMed
- Biotechniques. 1989 Oct;7(9):980-2, 984-6, 989-90 - PubMed
- Science. 1991 Nov 29;254(5036):1359-61 - PubMed
- Cell Regul. 1989 Nov;1(1):37-44 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous